{"id":1002751,"date":"2022-04-28T02:32:24","date_gmt":"2022-04-28T06:32:24","guid":{"rendered":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/edap-tms-s-a-nasdaqedap-expected-to-post-earnings-of-0-01-per-share-defense-world.php"},"modified":"2022-04-28T02:32:24","modified_gmt":"2022-04-28T06:32:24","slug":"edap-tms-s-a-nasdaqedap-expected-to-post-earnings-of-0-01-per-share-defense-world","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/tms\/edap-tms-s-a-nasdaqedap-expected-to-post-earnings-of-0-01-per-share-defense-world.php","title":{"rendered":"Edap Tms S.A. (NASDAQ:EDAP) Expected to Post Earnings of -$0.01 Per Share &#8211; Defense World"},"content":{"rendered":"<p><p>Wall Street analysts predict that Edap Tms S.A. (NASDAQ:EDAP  Get Rating) will post earnings per share of ($0.01) for the current quarter, Zacks reports. Two analysts have made estimates for Edap Tms earnings. The highest EPS estimate is $0.02 and the lowest is ($0.04). Edap Tms reported earnings per share of $0.03 in the same quarter last year, which indicates a negative year-over-year growth rate of 133.3%. The company is expected to issue its next earnings report  on Monday, January 1st.<\/p>\n<p>According to Zacks, analysts expect that Edap Tms will report full year earnings of ($0.08) per share for the current financial year, with EPS estimates ranging from ($0.13) to ($0.03). For the next financial year, analysts forecast that the firm will post earnings of ($0.04) per share, with EPS estimates ranging from ($0.11) to $0.03. Zacks Investment Researchs earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for Edap Tms.<\/p>\n<p>Edap Tms (NASDAQ:EDAP  Get Rating) last released its quarterly earnings data on Wednesday, March 30th. The medical equipment provider reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.03. Edap Tms had a net margin of 1.51% and a return on equity of 1.53%. During the same period in the prior year, the firm earned $0.03 earnings per share. <\/p>\n<p>Shares of EDAP remained flat at $$7.25 during mid-day trading on Friday. 60,951 shares of the stock traded hands, compared to its average volume of 67,022. The stock has a market cap of $241.50 million, a price-to-earnings ratio of 725.73 and a beta of 1.40. The company has a fifty day simple moving average of $7.27 and a 200 day simple moving average of $6.52. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.75 and a quick ratio of 3.34. Edap Tms has a twelve month low of $5.00 and a twelve month high of $7.88. <\/p>\n<p>A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Soleus Capital Management L.P. grew its position in  Edap Tms by 6.5% in the 4th quarter. Soleus Capital Management L.P. now owns 3,148,609 shares of the medical equipment providers stock worth $18,860,000 after purchasing an additional 192,242 shares during the last quarter.  Fosun International Ltd boosted its holdings in shares of  Edap Tms by 1.7% in the fourth quarter. Fosun International Ltd now owns 179,039 shares of the medical equipment providers stock valued at $949,000 after acquiring an additional 3,000 shares in the last quarter.  Envestnet Asset Management Inc. bought a new position in shares of  Edap Tms in the fourth quarter valued at approximately $94,000.  Toroso Investments LLC bought a new position in shares of  Edap Tms in the third quarter valued at approximately $126,000.  Finally, Morgan Stanley boosted its holdings in shares of  Edap Tms by 92.2% in the third quarter. Morgan Stanley now owns 1,497,285 shares of the medical equipment providers stock valued at $9,553,000 after acquiring an additional 718,460 shares in the last quarter. Hedge funds and other institutional investors own  27.20% of the companys stock. <\/p>\n<p>Edap Tms Company Profile (Get Rating)<\/p>\n<p>EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution.<\/p>\n<p>Featured Articles<\/p>\n<p>Get a free copy of the Zacks research report on Edap Tms (EDAP)<\/p>\n<p>For more information about research offerings from Zacks Investment Research, visit Zacks.com<\/p>\n<\/p>\n<p>Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Visit link: <\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.defenseworld.net\/2022\/04\/24\/edap-tms-s-a-nasdaqedap-expected-to-post-earnings-of-0-01-per-share.html\" title=\"Edap Tms S.A. (NASDAQ:EDAP) Expected to Post Earnings of -$0.01 Per Share - Defense World\">Edap Tms S.A. (NASDAQ:EDAP) Expected to Post Earnings of -$0.01 Per Share - Defense World<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Wall Street analysts predict that Edap Tms S.A. (NASDAQ:EDAP Get Rating) will post earnings per share of ($0.01) for the current quarter, Zacks reports. Two analysts have made estimates for Edap Tms earnings.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/tms\/edap-tms-s-a-nasdaqedap-expected-to-post-earnings-of-0-01-per-share-defense-world.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[431603],"tags":[],"class_list":["post-1002751","post","type-post","status-publish","format-standard","hentry","category-tms"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1002751"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1002751"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1002751\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1002751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1002751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1002751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}